Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence|SAMHSA
Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.
No hay comentarios:
Publicar un comentario